Literature DB >> 27612439

Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts.

Katsumasa Higashi1, Etsuko Matsuzaki2, Yoko Hashimoto1, Fumi Takahashi-Yanaga3, Aiko Takano1, Hisashi Anan4, Masato Hirata5, Fusanori Nishimura1.   

Abstract

Sphingosine-1-phosphate (S1P) is a signaling sphingolipid that also plays crucial roles in bone regeneration. Recently, we reported that the S1P receptors S1PR1 and S1PR2 were mainly expressed in osteoblast-like cells, and that the S1P/S1PR1 signaling pathway up-regulated osteoprotegerin and osteoblast differentiation. However, the involvement of S1P/S1PR2 signaling in osteoblast differentiation is not well understood. Here we investigate the role of S1P/S1PR2-mediated signaling in osteoblast differentiation and clarify the underlying signaling mechanisms. We found that an S1P/S1PR2/Gi-independent signaling pathway activated RhoA activity, leading to phosphorylation of Smad1/5/8 in mouse osteoblast-like MC3T3-E1 cells and primary osteoblasts. Furthermore, this signaling pathway promoted nuclear translocation of Smad4, and increased the amount of Smad6/7 protein in the nucleus. S1P also up-regulated runt-related transcription factor 2 (Runx2) expression through S1PR2/RhoA/ROCK/Smad1/5/8 signaling. Moreover, we found that S1P partially triggered S1PR2/RhoA/ROCK pathway leading to bone formation in vivo. These findings suggest that S1P induces RhoA activity, leading to the phosphorylation of Smad1/5/8, thereby promoting Runx2 expression and differentiation in osteoblasts. Our findings describe novel molecular mechanisms in S1P/S1PR2-mediated osteoblast differentiation that could aid future studies of bone regeneration.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Osteoblast; RhoA/ROCK; Runx2; Smads; Sphingosine-1-phosphate

Mesh:

Substances:

Year:  2016        PMID: 27612439     DOI: 10.1016/j.bone.2016.09.003

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  12 in total

1.  Sphingosine-1-phosphate receptor 2 agonist induces bone formation in rat apicoectomy and alveolar bone defect model.

Authors:  Etsuko Matsuzaki; Haruna Hirose; Seishiro Fujimasa; Shohei Yoshimoto; Tsukasa Yanagi; Kazuma Matsumoto; Misaki Nikaido; Masahiko Minakami; Noriyoshi Matsumoto; Hisashi Anan
Journal:  J Dent Sci       Date:  2021-10-19       Impact factor: 3.719

Review 2.  Dental regenerative therapy targeting sphingosine-1-phosphate (S1P) signaling pathway in endodontics.

Authors:  Etsuko Matsuzaki; Masahiko Minakami; Noriyoshi Matsumoto; Hisashi Anan
Journal:  Jpn Dent Sci Rev       Date:  2020-10-13

3.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

Review 4.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

5.  Sphingosine-1-Phosphate Modulates the Effect of Estrogen in Human Osteoblasts.

Authors:  Duangrat Tantikanlayaporn; Irina L Tourkova; Quitterie Larrouture; Jianhua Luo; Pawinee Piyachaturawat; Michelle R Witt; Harry C Blair; Lisa J Robinson
Journal:  JBMR Plus       Date:  2018-01-29

Review 6.  S1P-S1PR1 Signaling: the "Sphinx" in Osteoimmunology.

Authors:  Lan Xiao; Yinghong Zhou; Thor Friis; Kenneth Beagley; Yin Xiao
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

7.  Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca2+, and BMP/Smad Signaling.

Authors:  Simon Lin; Subramanya Pandruvada; Hong Yu
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

Review 8.  Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation.

Authors:  Kourosh Ahmadzadeh; Margot Vanoppen; Carlos D Rose; Patrick Matthys; Carine Helena Wouters
Journal:  Front Cell Dev Biol       Date:  2022-04-11

9.  The conserved p.Arg108 residue in S1PR2 (DFNB68) is fundamental for proper hearing: evidence from a consanguineous Iranian family.

Authors:  Michaela A H Hofrichter; Majid Mojarad; Julia Doll; Clemens Grimm; Atiye Eslahi; Neda Sadat Hosseini; Mohsen Rajati; Tobias Müller; Marcus Dittrich; Reza Maroofian; Thomas Haaf; Barbara Vona
Journal:  BMC Med Genet       Date:  2018-05-18       Impact factor: 2.103

Review 10.  Sphingosine-1-phosphate (S1P) receptors: Promising drug targets for treating bone-related diseases.

Authors:  Lincheng Zhang; Yutong Dong; Yiran Wang; Wenhui Hu; Shiwu Dong; Yueqi Chen
Journal:  J Cell Mol Med       Date:  2020-03-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.